Stratistics Market Research Consulting

Antifungal Drugs Market Report 2017, Trends, Analysis, Share, Estimates and Forecasts to 2022.

Press Release   •   Aug 08, 2017 02:39 EDT

“According to Stratistics MRC, the Global Antifungal Drugs Market is accounted for $13.2 billion in 2016 and is expected to reach $18.2 billion by 2022 growing at a CAGR of 5.4% during the forecast period”. Factors such as rising government and corporate financial support in the industry, growing awareness of fungal infections and increase in disposable income are fueling the market growth. However, generic competition and huge diffusion of conventional drugs used for the treatment of fungal infections are hampering the market growth. Cost of drugs and their effectiveness in treatment are major challenges in the market.

Dermatophytosis segment is anticipated to hold the largest market share during the forecast period due to increasing prevalence of skin infections in children. Candidiasis segment is expected to grow at the highest CAGR during the forecast period. North America is anticipated to account for the largest market share owing to the huge patient awareness levels and increased R&D spending pertaining to new drug development. Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to rising awareness towards personal safety and health care.

Some of the key players in Antifungal Drugs market include GlaxoSmithKline, Agilent Technologies, Inc., Kramer Laboratories, Bayer Healthcare, Abbott Laboratories, Novartis, Glenmark Pharmaceuticals Ltd, Merck & Co. Inc.,Pfizer Inc., Enzon Pharmaceuticals, PerkinElmer, Inc., Alternaria, Sigma-Aldrich and Astellas Pharma Inc.

For More, Please Visit: http://www.strategymrc.com/report/antifungal-drugs-market

Therapeutic Indications Covered:
• Candidiasis
• Dermatophytosis
• Aspergillosis
• Other Therapeutic Indications

Product Forms Covered:
• Liquids or Spray
• Shampoo
• Gels
• Injections
• Tablets (Pill)
• Cream

Drugs Types Covered:
• Polyenes
• Azoles
o Imidazole
o Thiazoles
o Voricanazole
o Triazole
• Allylamines
• Echinocandins
• Other Drugs Types

Distribution Channels Covered:
• Retail Pharmacies
• Specialty Clinics
• E-commerce
• Hospital Pharmacies

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

For More, Please Visit: http://www.strategymrc.com/report/antifungal-drugs-market

We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.